Bill's Page Views

This Week: 10   All-Time: 832

H.Con.Res.342 Add to

2 Comments

My Vote  All Votes
AyeAyes:3
NayNays:0

Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

previous 110th session of congress Other Bill Titles (1 more)

5/6/2008--Introduced.
Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.

Sponsor

Amendments

This bill has no amendments.



Bill Status

Make a Bill Status Widget What's This?
IntroducedresultVoted on by House
May 06, 2008
Show All Actions (3 actions)


Show More User Statistics...


In the News feed

May 08, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

The International Academy of Compounding Pharmacists joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342 ...

Was this article useful? Yes or No

Source: Medical News Today (press release), UK


May 07, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

"We commend all of the sponsors for standing up for women and introducing H. Con. Res. 342," said LD King. "Women with menopause suffer enough. ...

Was this article useful? Yes or No

Source: PharmaLive.com (press release), PA


May 07, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

"We commend all of the sponsors for standing up for women and introducing H. Con. Res. 342," said LD King. "Women with menopause suffer enough. ...

Was this article useful? Yes or No

Source: Earthtimes (press release), UK


1 more articles...
See most useful news articles

Information made available by:

Daylife

Blog Coverage feed

October 22, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

The International Academy of Compounding Pharmacists steady hundreds of thousands of women and doctors in root for the initial remarks of H. Con. Res. 342, a bipartisan foundation well-spoken that “the Food and Drug Administration’s ...

Was this article useful? Yes or No

Source: Womens Health Informer


October 03, 2008 Victory for Hormone Replacement Therapy Patients and Physicians!

... (IACP) has been inundated with requests from Capitol Hill staff for more information on BHRT and estriol. This means the final result we are hoping for – more co-sponsors for S. Con. Res. 88 and H. Con. Res. 342 – is within reach. ...

Was this article useful? Yes or No

Source: bodylogicmd's Hormone Therapy Blog


August 25, 2008 make health your life, n smile: [PozHealth] Fw: The Importance of ...

The U.S. House of Representatives and the U.S. Senate each have resolutions—H. Con. Res. 342 and S. Con Res. 88, respectively—calling for FDA to reverse its policy on estriol. The resolutions also call on the need for FDA to "respect ...

Was this article useful? Yes or No

Source: make health your life, n smile


29 more posts...
See most useful blog posts

Information made available by:

Technorati

For more info about the campaign contributions behind this bill, visit its page on Maplight.org

OpenCongress is a joint project of the Participatory Politics Foundation and the Sunlight Foundation


Read our Terms of Service and Privacy Policy     |     Questions? Comments? Contact Us

Data made available by

Govtrack.US

Help Open Congress

The OpenHouse Project